+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Clinical Nutrition Market By Route of Administration, By Application, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5094368
  • Report
  • May 2020
  • Region: North America
  • 87 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • B. Braun Melsungen AG
  • BASF SE
  • Hero Nutritionals, Inc.
  • Lonza Group AG
The North America Clinical Nutrition Market is expected to witness market growth of 6.2% CAGR during the forecast period (2020-2026).

Nutrition and diet are an important part of many health problems. A person is helped to preserve his health and wellbeing with a healthy diet and healthy intakes. Clinical nutrition is a form of nutrition for patients receiving medical care. Clinical nutrition is structured to preserve energy balance and provide essential nutrients such as calories, vitamins, and minerals. It also includes studies of nutrients important for the human body and the way the body is affected by nutrients.

Treatments for cancer can impair taste, smell, appetite, and ability to consume adequate food or absorb food nutrients. This can lead to malnutrition caused by a lack of important nutrients. The risk of malnutrition can rise with alcohol abuse and obesity. Malnutrition may contribute to fatigue, tiredness, and inability to fight illness or to end treatment of cancer. If cancer grows or spreads, malnutrition may become worse. This stresses the critical importance of clinical nutrition especially for treatment, infection control, and strength.

Neurological problems are also concerned with swallowing and starvation. In fact, the possibility of micronutrient loss and dehydration is enhanced for patients with neurological disorders. In comparison, the pathogenesis of neurological disorders may require dietary factors. The multiple causes of malnutrition are known for oropharyngeal dysphagia, impaired consciously, perception deficits, cognitive dysfunction, and increased need in neurological patients.

Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.

Scope of the Study

Market Segmentation:

By Route of Administration
  • Oral
  • Enteral and
  • Parenteral

By Application
  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders and
  • Other Applications

By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co., Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • B. Braun Melsungen AG
  • BASF SE
  • Hero Nutritionals, Inc.
  • Lonza Group AG

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Clinical Nutrition Market, by Route of Administration
1.4.2 North America Clinical Nutrition Market, by Application
1.4.3 North America Clinical Nutrition Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Jan - 2019, Dec) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2016, Mar - 2019, Oct) Leading Players
Chapter 4. North America Clinical Nutrition Market by Route Of Administration
4.1 North America Oral Market by Country
4.2 North America Enteral Market by Country
4.3 North America Parenteral Market by Country
Chapter 5. North America Clinical Nutrition Market by Application
5.1 North America Cancer Market by Country
5.2 North America Neurological Diseases Market by Country
5.3 North America Gastrointestinal Disorders Market by Country
5.4 North America Metabolic Disorders Market by Country
5.5 North America Other Applications Market by Country
Chapter 6. North America Clinical Nutrition Market by End User
6.1 North America Adults Clinical Nutrition Market by Country
6.2 North America Pediatric Market by Country
6.3 North America Geriatric Market by Country
Chapter 7. North America Clinical Nutrition Market by Country
7.1 US Clinical Nutrition Market
7.1.1 US Clinical Nutrition Market by Route Of Administration
7.1.2 US Clinical Nutrition Market by Application
7.1.3 US Clinical Nutrition Market by End User
7.2 Canada Clinical Nutrition Market
7.2.1 Canada Clinical Nutrition Market by Route Of Administration
7.2.2 Canada Clinical Nutrition Market by Application
7.2.3 Canada Clinical Nutrition Market by End User
7.3 Mexico Clinical Nutrition Market
7.3.1 Mexico Clinical Nutrition Market by Route Of Administration
7.3.2 Mexico Clinical Nutrition Market by Application
7.3.3 Mexico Clinical Nutrition Market by End User
7.4 Rest of North America Clinical Nutrition Market
7.4.1 Rest of North America Clinical Nutrition Market by Route Of Administration
7.4.2 Rest of North America Clinical Nutrition Market by Application
7.4.3 Rest of North America Clinical Nutrition Market by End User
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments
8.1.5.1 Acquisition and Mergers
8.1.5.2 Product Launches and Product Expansions
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments
8.2.5.1 Product Launches and Product Expansions
8.2.5.2 Partnerships, Collaborations, and Agreements
8.3 Baxter International, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments
8.3.5.1 Product Launches and Product Expansions
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Segmental and Regional Analysis
8.4.3 Research & Development Expense
8.4.4 Recent strategies and developments
8.4.4.1 Acquisition and Mergers
8.5 Nestle S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research& Development Expense
8.5.5 Recent strategies and developments
8.5.5.1 Partnerships, Collaborations, and Agreements
8.5.5.2 Product Launches and Product Expansions
8.5.5.3 Geographical Expansions
8.6 Lonza Group AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments
8.6.5.1 Partnerships, Collaborations, and Agreements
8.6.5.2 Product Launches and Product Expansions
8.6.5.3 Acquisition and Mergers
8.7 BASF SE
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments
8.7.5.1 Partnerships, Collaborations, and Agreements
8.8 Ajinomoto Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments
8.8.5.1 Partnerships, Collaborations, and Agreements
8.8.5.2 Acquisition and Mergers
8.9 Perrigo Company PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10 Hero Nutritionals, Inc.
8.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co., Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...